RU2005109272A - Улучшенные агенты визуализации, содержащие производные барбитуровой кислоты - Google Patents

Улучшенные агенты визуализации, содержащие производные барбитуровой кислоты Download PDF

Info

Publication number
RU2005109272A
RU2005109272A RU2005109272/15A RU2005109272A RU2005109272A RU 2005109272 A RU2005109272 A RU 2005109272A RU 2005109272/15 A RU2005109272/15 A RU 2005109272/15A RU 2005109272 A RU2005109272 A RU 2005109272A RU 2005109272 A RU2005109272 A RU 2005109272A
Authority
RU
Russia
Prior art keywords
radioactive
group
agent according
barbituric acid
visualization
Prior art date
Application number
RU2005109272/15A
Other languages
English (en)
Russian (ru)
Inventor
Клаус КОПКА (DE)
Клаус КОПКА
Ханс-Йорг БРАЙХОЛЬЦ (DE)
Ханс-Йорг БРАЙХОЛЬЦ
Стефан ВАГНЕР (DE)
Стефан ВАГНЕР
Михаэль ШАФЕРС (DE)
Михаэль ШАФЕРС
Бодо ЛЕФКАУ (DE)
Бодо ЛЕФКАУ
Бенедикт ЖИЛЬБЕР (GB)
Бенедикт ЖИЛЬБЕР
Данкан УИНН (GB)
Данкан УИНН
Original Assignee
Джи-И Хелткер Лимитед (GB)
Джи-И Хелткер Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Джи-И Хелткер Лимитед (GB), Джи-И Хелткер Лимитед filed Critical Джи-И Хелткер Лимитед (GB)
Publication of RU2005109272A publication Critical patent/RU2005109272A/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0438—Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0459—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
RU2005109272/15A 2002-10-08 2003-10-08 Улучшенные агенты визуализации, содержащие производные барбитуровой кислоты RU2005109272A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0223249.4 2002-10-08
GBGB0223249.4A GB0223249D0 (en) 2002-10-08 2002-10-08 Improved imaging agents

Publications (1)

Publication Number Publication Date
RU2005109272A true RU2005109272A (ru) 2006-01-27

Family

ID=9945439

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2005109272/15A RU2005109272A (ru) 2002-10-08 2003-10-08 Улучшенные агенты визуализации, содержащие производные барбитуровой кислоты

Country Status (10)

Country Link
US (1) US20060120956A1 (https=)
EP (1) EP1549317A1 (https=)
JP (1) JP2006505550A (https=)
CN (1) CN1720050A (https=)
AU (1) AU2003273505B2 (https=)
CA (1) CA2501136A1 (https=)
GB (1) GB0223249D0 (https=)
NO (1) NO20051641L (https=)
RU (1) RU2005109272A (https=)
WO (1) WO2004032936A1 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2448733C2 (ru) * 2006-06-21 2012-04-27 Джи-И Хелткер Лимитед Радиофармацевтические продукты
RU2473361C2 (ru) * 2007-05-16 2013-01-27 ДжиИ Хелткер АС Меченые пептиды, связывающие фактор роста гепатоцитов (hgf), для визуализации

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006021495A1 (de) * 2006-05-09 2007-11-15 Bayer Schering Pharma Ag Verwendung von perfluoralkylhaltigen Metallkomplexen als Kontrastmittel zur Diagnose der Alzheimer Krankheit
PL2029178T3 (pl) 2006-06-21 2012-08-31 Ge Healthcare Ltd Produkty radiofarmaceutyczne
GB0718386D0 (en) * 2007-09-21 2007-10-31 Ge Healthcare As Improved radiopharmaceutical formulation
GB201115937D0 (en) 2011-09-14 2011-10-26 Univ Aberdeen 18F-labelled compounds for use as positron emission imaging agents
JP2021534215A (ja) * 2018-08-24 2021-12-09 ゼニオプロ ゲーエムベーハー 病的症状の治療における使用のための芳香族分子

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3952971A (en) * 1971-11-09 1976-04-27 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Airfoil shape for flight at subsonic speeds
US3952091A (en) * 1974-10-23 1976-04-20 Hoffmann-La Roche Inc. Simultaneous multiple radioimmunoassay
GB1527416A (en) * 1976-07-20 1978-10-04 Ciba Geigy Ag Photopolymerisible diepoxides
US6472227B1 (en) * 1986-06-04 2002-10-29 Abbott Laboratories Barbiturate assay, tracers, immunogens, antibodies and kit
US5102786A (en) * 1987-05-21 1992-04-07 Pb Diagnostic Systems, Inc. Biological diagnostic assay system
IL139385A (en) * 1998-05-15 2005-09-25 Amersham Plc Labelled glutamine and lysine analogues, metal complexes thereof, and uses thereof for diagnosis
US6656448B1 (en) * 2000-02-15 2003-12-02 Bristol-Myers Squibb Pharma Company Matrix metalloproteinase inhibitors
DE60114022T2 (de) * 2000-05-30 2006-07-13 Board Of Governors Of Wayne State University, Detroit Matrix metalloproteinase-inhibitoren
CN1501937A (zh) * 2000-10-26 2004-06-02 �Ʒ� 螺-嘧啶-2,4,6-三酮金属蛋白酶抑制剂
HUP0302337A3 (en) * 2000-10-26 2004-01-28 Pfizer Prod Inc Pyrimidine-2,4,6-trione metalloproteinase inhibitors, pharmaceutical compositions containing them and their use
CN100336521C (zh) * 2000-12-12 2007-09-12 血管实验室公司 蜜蜂花叶提取物制备抑制血管生成相关疾病药物的用途
GB0115929D0 (en) * 2001-06-29 2001-08-22 Nycomed Amersham Plc Solid-phase electrophilic fluorination

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2448733C2 (ru) * 2006-06-21 2012-04-27 Джи-И Хелткер Лимитед Радиофармацевтические продукты
RU2473361C2 (ru) * 2007-05-16 2013-01-27 ДжиИ Хелткер АС Меченые пептиды, связывающие фактор роста гепатоцитов (hgf), для визуализации
RU2473361C9 (ru) * 2007-05-16 2013-06-20 ДжиИ Хелткер АС Меченые пептиды, связывающие фактор роста гепатоцитов (hgf), для визуализации

Also Published As

Publication number Publication date
NO20051641L (no) 2005-06-02
CN1720050A (zh) 2006-01-11
AU2003273505A1 (en) 2004-05-04
EP1549317A1 (en) 2005-07-06
GB0223249D0 (en) 2002-11-13
US20060120956A1 (en) 2006-06-08
CA2501136A1 (en) 2004-04-22
AU2003273505B2 (en) 2007-04-19
JP2006505550A (ja) 2006-02-16
WO2004032936A1 (en) 2004-04-22

Similar Documents

Publication Publication Date Title
RU2006117298A (ru) Визуализирующие агенты на основе ингибитора
RU2006117819A (ru) Новые агенты визуализации, содержащие ингибиторы каспазы-3
JP2006528205A5 (https=)
CA1253799A (en) Nmr contrast agents
US5419894A (en) Complexing agents, complexes and complex salts
RU2003108256A (ru) Производные тиофлавина, связывающие амилоид (варианты), и способ их получения (варианты), фармацевтическая композиция для визуализации in vivo отложений амилоида, способ обнаружения отложений амилоида (варианты), способ определения количества амилоида в биоптате или полученной посмертно ткани, спосооб распознавания боолезни альцгеймера
KR960702447A (ko) 간담용 자기공명 콘트라스트제(hepatobiliary magnetic resonance contrast agents)
JP2854905B2 (ja) キレート組成物
JP2010503685A (ja) インテグリンのためのイメージング剤としてのクリック化学由来シクロペプチド誘導体
JPH07506592A (ja) 造影用のテクネチウム‐９９ｍ標識ペプチド
AU2006261917A1 (en) Radiolabeled-pegylation of ligands for use as imaging agents
RU2005109272A (ru) Улучшенные агенты визуализации, содержащие производные барбитуровой кислоты
AU587637B2 (en) Carboxy,carboalkoxy and carbamyl substituted isonitrile radionuclide complexes
RU2007110372A (ru) Агенты визуализации, ингибирующие металлопротеиназу
CA2465554A1 (en) Quinoline derivatives as probes for the diagnosis of diseases in which tau protein accumulates
WO2013172979A1 (en) Methods and compositions for positron emission tomography myocardial perfusion imaging
RU2005123801A (ru) Агенты для диагностической визуализации, обладающие ингибирующей активностью в отношении матриксных металлопротеиназ (ммро)
JP2006519216A5 (https=)
EP2091570A1 (en) Contrast agents
JP2006505550A5 (https=)
CN101687803B (zh) 具有全氟化的peg基团的金属螯合物、它们的制备方法及它们的用途
RU2007118548A (ru) Соединение для визуализации перфузии миокарда
CA2197074A1 (en) Dimer dtpa derivatives and their metal complexes, pharmaceuticals containing the same, their use in diagnosis and therapy and process for preparing said complexes and pharmaceuticals
CA2098712A1 (en) Chelating agents
WO2014122228A1 (en) Labelled compounds that bind to alpha-v-beta-3 integrin

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20080303